Mitchells & Butlers PLC
XBER:MABB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Mitchells & Butlers PLC
XBER:MABB
|
UK |
|
I
|
Innocan Pharma Corp
XMUN:IP4
|
IL |
|
C
|
City of London Investment Group PLC
XBER:W8T
|
UK |
|
W
|
Webjet Ltd
F:WBJ
|
AU |
Wall St Price Targets
MABB Price Targets Summary
Mitchells & Butlers PLC
According to Wall Street analysts, the average 1-year price target for MABB is 4.53 EUR with a low forecast of 4.1 EUR and a high forecast of 5.11 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MABB's stock price target?
Price Target
4.53
EUR
According to Wall Street analysts, the average 1-year price target for MABB is 4.53 EUR with a low forecast of 4.1 EUR and a high forecast of 5.11 EUR.
What is the Revenue forecast for Mitchells & Butlers PLC?
Projected CAGR
4%
Over the last 14 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 3 years is 4%.
What is the Operating Income forecast for Mitchells & Butlers PLC?
Projected CAGR
4%
Over the last 14 years, the compound annual growth rate for Operating Income has been 1%. The projected CAGR for the next 3 years is 4%.
What is the Net Income forecast for Mitchells & Butlers PLC?
Projected CAGR
9%
Over the last 14 years, the compound annual growth rate for Net Income has been 3%. The projected CAGR for the next 3 years is 9%.
